These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3044722)

  • 1. [Renoparenchymal hypertension. Is there a specific therapy?].
    Geiger H; Bahner U; Heidland A
    Dtsch Med Wochenschr; 1988 Aug; 113(33):1290-5. PubMed ID: 3044722
    [No Abstract]   [Full Text] [Related]  

  • 2. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive therapy in renal failure].
    Mayer G
    Acta Med Austriaca; 1995; 22(3):51-3. PubMed ID: 8571752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of renoparenchymal hypertension in chronic glomerulonephritis with normal and impaired renal function].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):49-53. PubMed ID: 7164406
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renoparenchymal hypertension].
    Mühlhauser I; Sawicki P; Berger M
    Dtsch Med Wochenschr; 1989 Apr; 114(17):689-90. PubMed ID: 2707137
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
    Giverhaug T; Falck A; Eriksen BO
    J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood pressure control on the progression of renal insufficiency in chronic renal failure.
    Branca GF; Satta A; Faedda R; Soggia G; Olmeo NA; Vacca R; Bartoli E
    Panminerva Med; 1983; 25(4):215-8. PubMed ID: 6672713
    [No Abstract]   [Full Text] [Related]  

  • 10. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of noninvasive 24-hour blood pressure measurement in patients with renoparenchymal, renovascular or severe essential hypertension].
    Hollenbeck M; Kutkuhn B; Bosma A; Morgera S; Grabensee B
    Z Kardiol; 1992; 81 Suppl 2():29-32. PubMed ID: 1514308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.
    Lazarus JM; Hampers C; Merrill JP
    Arch Intern Med; 1974 Jun; 133(6):1059-66. PubMed ID: 4597951
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal and endocrine hypertension. A review.
    Chan JC
    Int J Pediatr Nephrol; 1983 Sep; 4(3):187-96. PubMed ID: 6358076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment and prognosis of renal hypertension].
    Oshima K; Takeda T; Fukuchi S; Abe K; Kajiwara N
    Jpn Circ J; 1974 Apr; 38():Suppl:93-7. PubMed ID: 4406378
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition: facts and fiction.
    Tamimi N; El Nahas AM
    Nephron; 2000 Apr; 84(4):299-304. PubMed ID: 10754405
    [No Abstract]   [Full Text] [Related]  

  • 16. [Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
    Stiefelhagen P
    MMW Fortschr Med; 2005 Apr; 147(16):4-6. PubMed ID: 16392389
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of hypotensive and pathogenetic therapy on the propulsive function of the heart in patients with glomerulonephritis].
    Zharko KP; Tarnakina TP; Akhmed DI
    Vrach Delo; 1989 Sep; (9):71-3. PubMed ID: 2609629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in the child with chronic renal insufficiency or undergoing dialysis.
    Solhaug MJ; Adelman RD; Chan JC
    Child Nephrol Urol; 1992; 12(2-3):133-8. PubMed ID: 1628271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.